|STAA||STAAR SURGICAL CO||2.13%|
|TWST||TWIST BIOSCIENCE CORP USD 0.00001||2.03%|
|TXG||10X GENOMICS INC||2.03%|
|BCRX||BIOCRYST PHARMACEUTICALS INC||2.03%|
|EXAS||EXACT SCIENCES CORP||1.99%|
|NTLA||INTELLIA THERAPEUTICS INC||1.98%|
|CRSP||CRISPR THERAPEUTICS AG||1.98%|
|IMAB||I-MAB CNY 0.0001 ADR||1.89%|
|SWTX||SPRINGWORKS THERAPEUTICS USD||1.80%|
|TPTX||TURNING PT THERAPEUTICS||1.79%|
|EW||EDWARDS LIFESCIENCES CORP||1.78%|
|LLY||ELI LILLY CORP||1.78%|
|ITCI||INTRA-CELLULAR THERAPIES USD||1.78%|
|NRIX||NURIX THERAPEUTICS INC||1.74%|
|ARVN||ARVINAS INC USD||1.73%|
|ZLAB||ZAI LAB LTD||1.73%|
|BGNE||BEIGENE LTD USD 0.0001 ADR||1.73%|
|TGTX||TG THERAPEUTICS INC||1.73%|
|ARNA||ARENA PHARMACEUTICALS INC||1.72%|
|FATE||FATE THERAPEUTICS INC||1.70%|
|BBIO||BRIDGEBIO PHARMA INC||1.68%|
|GH||GUARDANT HEALTH INC||1.66%|
|ASND||ASCENDIS PHARMA A/S DKK 1.0 ADR||1.65%|
|GTHX||G1 THERAPEUTICS INC||1.63%|
|CTLT||CATALENT INC USD 0.01||1.63%|
|RCKT||ROCKET PHARMACEUTICALS INC USD||1.62%|
|SRRK||SCHOLAR ROCK HLDG CORP USD||1.60%|
|SRPT||SAREPTA THERAPEUTICS INC||1.59%|
|CRL||CHARLES RIVER LABORATORIES INT INC||1.58%|
|HZNP||HORIZON THERAPEUTICS PLC||1.57%|
|BMY||BRISTOL MYERS SQUIBB CO||1.53%|
|XLRN||ACCELERON PHARMA INC||1.50%|
|MOH||MOLINA HEALTHCARE INC||1.50%|
|XRAY||DENTSPLY SIRONA INC||1.45%|
|HCA||HCA HOLDINGS INC||1.45%|
|LH||LABORATORY CORP OF AMERICA||1.44%|
|TCRR||TCR2 THERAPEUTICS INC||1.40%|
|RARE||ULTRAGENYX PHARMACEUTICAL INC||1.28%|
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2021 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.